![Ian Karp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Karp
Investor Relations Kontakt på
COLLEGIUM PHARMACEUTICAL, INC.
Profil
Ian Karp is currently Head-Investor Relations at Collegium Pharmaceutical, Inc. Former positions include Senior Director-Global Marketing at MedImmune LLC, Vice President & Head-Investor Relations at Shire Plc from 2016 to 2017, Senior Vice President-Investor & Public Relations at Karyopharm Therapeutics, Inc., and Senior Vice President-Corporate Communications at Intellia Therapeutics, Inc. Education includes an undergraduate degree from Emory University and an MBA from Rutgers Business School.
Aktiva positioner av Ian Karp
| Företag | Position | Start |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Investor Relations Kontakt | - |
Tidigare kända positioner av Ian Karp
| Företag | Position | Slut |
|---|---|---|
| SHIRE | Investor Relations Kontakt | 2017-12-01 |
| INTELLIA THERAPEUTICS, INC. | Offentlig kommunikationskontakt | - |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Försäljning & Marknadsföring | - |
| KARYOPHARM THERAPEUTICS INC. | Investor Relations Kontakt | - |
Ian Karps utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
44
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
